NASDAQ · Medical - Devices

BVS (BVS) Stock

$13.12 -0.68% NASDAQ: BVS Healthcare

Valuation

MetricValue
Price$13.12
Market Cap$888.85M
P/E Ratio20.85
P/B Ratio3.06
P/S Ratio1.01
EPS (TTM)$0.34
52-Week High$13.12
52-Week Low$5.81
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE16.46%
ROA5.61%
ROCE25.76%
Gross Margin67.78%
Operating Margin10.64%
Net Margin4.94%
Debt/Equity1.44
Current Ratio1.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$431.0M$512.0M$512.0M$573.0M$568.0M
Operating Profit$12.0M$-167.0M$-82.0M$-12.0M$59.0M
Net Profit$19.0M$-159.0M$-156.0M$-34.0M$23.0M
EPS$-0.15$-2.59$-2.49$-0.52$0.33
Op Margin2.8%-32.7%-15.9%-2.1%10.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.2B$1.4B$811.0M$728.0M$684.0M
Total Liabilities$692.0M$960.0M$590.0M$542.0M$455.0M
Cash$44.0M$30.0M$37.0M$42.0M$51.0M
Borrowings$358.0M$418.0M$395.0M$336.0M$311.0M

Latest News

Bioventus (BVS) Stock Looks Overvalued On Earnings Yet Backed By Broader Checks Simply Wall St. · Jul 10, 2026 Are Medical Stocks Lagging Caribou Biosciences (CRBU) This Year? Zacks · Jul 9, 2026 Are You Looking for a Top Momentum Pick? Why Bioventus (BVS) is a Great Choice Zacks · Jul 8, 2026 Wall Street Analysts Predict a 28.81% Upside in Bioventus (BVS): Here's What You Should Know Zacks · Jul 8, 2026 Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock? Zacks · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$23.0M$-14.0M$15.0M$39.0M$74.0M
Investing Cash Flow$-305.0M$-118.0M$8.0M$22.0M$-8.0M
Financing Cash Flow$-2.0M$-3.0M$-4.0M$3.0M$-21.0M
Net Cash Flow$12.0M$-67.0M$5.0M$5.0M$10.0M
Free Cash Flow$2.0M$-15.0M$8.0M$38.0M$71.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.10
EV / EBITDA10.81
FCF Yield17.36%
Quick Ratio1.13
Interest Coverage2.27
Return 1Y77.43%
Return 3Y222.47%
Return 5Y-28.42%

Ownership

Insiders Held11.75%
Institutions Held78.33%
Institutions Float Held88.76%
Institutional HolderSharesReport Date
Essex Woodlands Management Inc.13,021,3242026-03-31
Juniper Investment Company, LLC6,939,3572026-03-31
Nantahala Capital Management, LLC6,122,4032026-03-31
Blackrock Inc.3,133,5412026-03-31
Vanguard Capital Management LLC1,714,7072026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AVNS $24.99 +0.04% 19.96 $1.17B 0.00%
BFLY $8.28 -1.72% -60.65 $2.20B 0.00%
CBLL $18.81 +3.07% -11.62 $713.70M 0.00%
CTKB $4.38 -1.79% -7.25 $565.64M 0.00%
KIDS $22.77 -0.26% -10.79 $584.85M 0.00%

About BVS

BVS is led by CEO Robert E. Claypoole, employs 930 people, headquartered in US, publicly traded since 2021.

BVS stock trades at $13.12 with a market capitalization of $888.85M. The stock is valued at a price-to-earnings (P/E) ratio of 20.85, price-to-book of 3.06, price-to-sales of 1.01. Over the past 52 weeks the stock has ranged between $5.81 and $13.12, and currently trades at its 52-week high.

On profitability, BVS generates a return on equity (ROE) of 16.46%, above the typical market average, return on capital employed of 25.76%, an operating margin of 10.64%, a net profit margin of 4.94%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides